Xtant Medical Holdings, Inc. (XTNT) Gross margin 2016–2025
Xtant Medical Holdings, Inc. (XTNT) gross margin by fiscal year — reported gross profit divided by reported revenue.
62.9%FY2025 · since FY2016: 69.2% → 62.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.9% | +4.8 pp |
| FY2024 | 58.2% | -2.6 pp |
| FY2023 | 60.8% | +5.3 pp |
| FY2022 | 55.4% | -3.4 pp |
| FY2021 | 58.8% | -5.7 pp |
| FY2020 | 64.5% | -1.3 pp |
| FY2019 | 65.7% | +5.5 pp |
| FY2018 | 60.2% | -0.4 pp |
| FY2017 | 60.6% | -8.6 pp |
| FY2016 | 69.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice